Who knows anymore right fabius, but right now IPCI mgmt. has collected millions in bonuses on attaining 4 FDA approved generics...yet is barely generating $300K in revenue per quarter despite having 4 FDA approved ANDA's under their collective hats...which is a downright ludicrous value proposition for market consideration.
I would love for IPCI mgmt. to tell their core shareholders how they feel justified lining their collective pockets in bonuses from their 4 FDA approved ANDA's to only deliver a pathetic/paltry revenue run rate of $300K per quarter!